Publication | Open Access

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematologyMulticentre Zuma-3 StudyPhase 2Adult T-cell Leukemia-lymphomaOncologyRadiation OncologyCancer ResearchHealth Sciences